article graphic

News & insights

Filter by:

Filters

Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises EIC Fund and NRW.BANK on EUR 57 million Series A financing round of eleQtron

21 May 2026

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Competition, EU & trade

EU authorized new sanctions against Russia

General overview of the sanctions regime and explaination what companies need to do now

20 May 2026
Briefing

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises the shareholders of anemos Gesellschaft für Umweltmeteorologie GmbH on the sale of the entire company to Vidia GmbH

20 May 2026

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Environmental, planning & regulatory

The German Government’s Grid Package: New Rules for Grid Connection

11 May 2026
Briefing

by Dr. Christian Ertel

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
UPC

New Court, new approaches: How the UPC is reshaping pharmaceutical patent litigation

11 May 2026
In-depth analysis

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Commercial & consumer contracts

PPWR & Distribution/Franchising: Packaging compliance as a strategic necessity

8 May 2026
Briefing

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Brands & advertising

Managing IP Awards 2026: Taylor Wessing Germany named “Trademark Firm of the Year” once again

6 May 2026

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Banking & finance

Cabinet decision on the Statutory Health Insurance Contribution Stabilization Act – Financial burdens on German pharmaceutical companies

4 May 2026
Briefing

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products

29 April 2026
Briefing

by Daniel Dietrich and Dr. Daniel Tietjen

Click here to find out more
Call To Action Arrow Image

Events

Hear from our experts as they discuss the latest legal issues.

Browse our events
Browse our events